Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side ...

After a rough reception and a rebrand to support users of GLP-1 drugs, Peoplehood is selling its assets to WeightWatchers.

In what Epic Games’ CEO describes as a “[t]otal victory in the Epic v. Google appeal”, on July 31, the United States Court of Appeals for the ...

Coal's popularity as an investment has been going down the chute since the early 2000s, but energy consulting firm group Wood Mackenzie recently laid out a trajectory that coal demand could stay ...

Shares in Novo Nordisk rose as much as 14% on Thursday after trial data from Eli Lilly's experimental weight-loss pill fell ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

ETM aligns with EU critical minerals goal; a production boost at Omani copper-gold project ... Read More The post Resources ...

The news comes days after Novo cut its full-year outlook due to rising competition from copycat compounders, and named a new ...

Brentwood, Tenn.-based Surgery Partners is doubling down on independence following the decision not to proceed with Bain Capital’s proposed acquisition, according to the company’s second quarter ...

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...